Euro area - Prevalence of HIV, total (% of population ages 15-49)

Prevalence of HIV, total (% of population ages 15-49) in Euro area was 0.223 as of 2020. Its highest value over the past 30 years was 0.250 in 2012, while its lowest value was 0.140 in 1990.

Definition: Prevalence of HIV refers to the percentage of people ages 15-49 who are infected with HIV.

Source: UNAIDS estimates.

See also:

Year Value
1990 0.140
1991 0.158
1992 0.163
1993 0.190
1994 0.195
1995 0.195
1996 0.195
1997 0.196
1998 0.196
1999 0.201
2000 0.201
2001 0.202
2002 0.203
2003 0.204
2004 0.206
2005 0.207
2006 0.214
2007 0.215
2008 0.241
2009 0.242
2010 0.242
2011 0.245
2012 0.250
2013 0.250
2014 0.250
2015 0.249
2016 0.249
2017 0.248
2018 0.248
2019 0.223
2020 0.223

Limitations and Exceptions: The limited availability of data on health status is a major constraint in assessing the health situation in developing countries. Surveillance data are lacking for many major public health concerns. Estimates of prevalence and incidence are available for some diseases but are often unreliable and incomplete. National health authorities differ widely in capacity and willingness to collect or report information.

Statistical Concept and Methodology: HIV prevalence rates reflect the rate of HIV infection in each country's population. Low national prevalence rates can be misleading, however. They often disguise epidemics that are initially concentrated in certain localities or population groups and threaten to spill over into the wider population. In many developing countries most new infections occur in young adults, with young women especially vulnerable. Data on HIV are from the Joint United Nations Programme on HIV/AIDS (UNAIDS). Changes in procedures and assumptions for estimating the data and better coordination with countries have resulted in improved estimates of HIV and AIDS. The models, which are routinely updated, track the course of HIV epidemics and their impact, making full use of information in HIV prevalence trends from surveillance data as well as survey data. The models take into account reduced infectivity among people receiving antiretroviral therapy (which is having a larger impact on HIV prevalence and allowing HIV-positive people to live longer) and allow for changes in urbanization over time in generalized epidemics. The estimates include plausibility bounds, which reflect the certainty associated with each of the estimates.

Aggregation method: Weighted average

Periodicity: Annual

Classification

Topic: Health Indicators

Sub-Topic: Risk factors